Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VALN | STTK |
|---|---|---|
| Price | $5.87 | $5.66 |
| Change today | ▲ 0.17% | ▼ 3.50% |
| Market cap | $556.61M | $567.55M |
| Return, 3 months | +10.9% | -19.6% |
| Return, year to date | -33.4% | +54.9% |
| Return, 1 year | -46.8% | +136.6% |
| P/E (TTM) | -2.9 | -12.9 |
| P/B | 6.1 | 2.7 |
| P/E percentile vs own 5y | 89th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -27.7% | – |
| Net profit growth (YoY) | -169.3% | -21.6% |
| Gross margin | 16.4% | – |
| Operating margin | -80.4% | -5,578.6% |
| Net margin | -110.3% | -5,256.8% |
| Return on equity | -117.8% | -39.2% |
| Analyst target vs. price | +132.9% | +180.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 39 | 35 |
| 30-day volatility | 43.2% | 56.1% |
| Max drawdown, 1 year | -60.8% | -50.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
